Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr₹35 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹1,019 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹1,019 Cr
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr
Mar2021₹35 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹1,019 Cr
1,045.33
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr
137.32
Mar2021 ₹35 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,318.8 Cr -0.4% -3.3% 1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,428.0 Cr 1.5% -3% 6.7% Stock Analytics
DIVIS LABORATORIES ₹175,426.0 Cr -2.2% -4.5% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,603.0 Cr 0.8% 2.3% 43.9% Stock Analytics
CIPLA ₹111,604.0 Cr 0.4% -4% -7.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,775.0 Cr 0.8% -1.8% -3.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.4%

-3.3%

1%

SENSEX

3.7%

2.2%

-7.2%


You may also like the below Video Courses